Prout Samantha
- SEC CIK
- 0001743122
No open-market purchases or sales filed in the past year.
Current role at each company
- FOLD Amicus Therapeutics, Inc.Chief Accounting Officeras of Apr 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Prout Samantha as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 (view filing) | Jan 8-9 | 1 day | Prout SamanthaChief Accounting Officer | SSale | −32.1K | $14.00 | −$449.5K | −28.4%81.0K after | 2 lots10b5-1 |
| Dec 28, 2023 (view filing) | Dec 26 | 2 days | Prout SamanthaChief Accounting Officer | SSale | −7.66K | $14.00 | −$107.2K | −5.9%121.9K after | 10b5-1 |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Prout SamanthaChief Accounting Officer | SSale | −36.9K | $14.01 | −$517.1K | −21.2%137.0K after | 10b5-1 |
| Sep 8, 2021 (view filing) | Sep 3 | 5 days | Prout SamanthaPrincipal Accounting Officer | SSale | −4.92K | $12.01 | −$59.1K | −5.6%83.2K after | |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Prout SamanthaPrincipal Accounting Officer | SSale | −5.04K | $11.00 | −$55.5K | −5.7%83.2K after |